BVT Aktienanleihe AMD 31.12.2024/ DE000VM3PPP6 /
| 2024-05-31 8:03:24 PM | Chg.-0.040 | Bid9:59:36 PM | Ask9:59:36 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 101.410EUR | -0.04% | - Bid Size: - |
- Ask Size: - |
Advanced Micro Devic... | 70.00 USD | 2024-12-31 | Call |
GlobeNewswire
6:00 AM
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...
GlobeNewswire
5:01 AM
AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
GlobeNewswire
5:00 AM
AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Road...
GlobeNewswire
4:59 AM
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire
06-02
Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial Revolu...
GlobeNewswire
05-28
AMD Chair and Chief Executive Officer Dr. Lisa Su to Deliver the Opening Keynote at Computex 2024
GlobeNewswire
05-28
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizuma...
GlobeNewswire
05-28
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
05-21
AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire
05-21
AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...
GlobeNewswire
05-21
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire
05-21
YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
GlobeNewswire
05-20
Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs
Newsfile Corp
05-16
FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization
GlobeNewswire
05-15
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...
GlobeNewswire
05-14
Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire
05-14
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
GlobeNewswire
05-14
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-13
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...
